Emory receives $2.2 million from CDC to research anti-HIV gel

<p>Emory University has received $2.2 million from the government for clinical trials of promising anti-HIV microbicides, university officials said.</p><p>Emory Vaccine Center's Hope Clinic in Decatur received the grant from the Centers for Disease Control and Prevention.</p><p>The study will be the first of its kind in Atlanta to evaluate the safety and acceptability of use of microbicides for healthy women and women with HIV. Two different microbicide gels will be tested.</p><p>Health officials hope to find a gel that could kill the virus to reduce or prevent sexual HIV transmission. Finding one could have a worldwide impact on the HIV epidemic, Hope Clinic director Dr. Frances Priddy said in a statement.</p><p>Patients will be recruited later this year.</p>